Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $72.9B |
| FY2017, ended Dec 31, 2017 | $103B |
| FY2018, ended Dec 31, 2018 | $88.7B |
| FY2019, ended Dec 31, 2019 | $120B |
| FY2020, ended Dec 31, 2020 | $151B |
| FY2021, ended Dec 31, 2021 | $174B |
| FY2022, ended Dec 31, 2022 | $150B |
| FY2023, ended Dec 31, 2023 | $155B |
| FY2024, ended Dec 31, 2024 | $171B |
| FY2025, ended Dec 31, 2025 | $157B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $256B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $13.4B |
| FY2017, ended Dec 31, 2017 | $15.0B |
| FY2018, ended Dec 31, 2018 | $15.8B |
| FY2019, ended Dec 31, 2019 | $14.4B |
| FY2020, ended Dec 31, 2020 | $14.5B |
| FY2021, ended Dec 31, 2021 | $18.3B |
| FY2022, ended Dec 31, 2022 | $20.0B |
| FY2023, ended Dec 31, 2023 | $17.5B |
| FY2024, ended Dec 31, 2024 | $15.6B |
| FY2025, ended Dec 31, 2025 | $17.7B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $20.8B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.60B | $4.08B |
| FY2017, ended Dec 31, 2017 | $3.68B | $4.67B |
| FY2018, ended Dec 31, 2018 | $5.58B | $6.06B |
| FY2019, ended Dec 31, 2019 | $5.02B | $5.80B |
| FY2020, ended Dec 31, 2020 | $5.59B | $5.49B |
| FY2021, ended Dec 31, 2021 | $7.77B | $6.29B |
| FY2022, ended Dec 31, 2022 | $8.75B | $5.92B |
| FY2023, ended Dec 31, 2023 | $6.51B | $1.35B |
| FY2024, ended Dec 31, 2024 | $4.80B | $1.50B |
| FY2025, ended Dec 31, 2025 | $5.00B | $2.60B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $7.11B | $7.32B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.15B |
| FY2017, ended Dec 31, 2017 | $1.66B |
| FY2018, ended Dec 31, 2018 | $2.44B |
| FY2019, ended Dec 31, 2019 | $2.44B |
| FY2020, ended Dec 31, 2020 | $3.11B |
| FY2021, ended Dec 31, 2021 | $4.63B |
| FY2022, ended Dec 31, 2022 | $3.05B |
| FY2023, ended Dec 31, 2023 | $2.96B |
| FY2024, ended Dec 31, 2024 | $3.20B |
| FY2025, ended Dec 31, 2025 | $3.23B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $4.21B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.61B |
| FY2017, ended Dec 31, 2017 | $4.08B |
| FY2018, ended Dec 31, 2018 | $5.07B |
| FY2019, ended Dec 31, 2019 | $5.80B |
| FY2020, ended Dec 31, 2020 | $6.80B |
| FY2021, ended Dec 31, 2021 | $7.74B |
| FY2022, ended Dec 31, 2022 | $8.73B |
| FY2023, ended Dec 31, 2023 | $11.2B |
| FY2024, ended Dec 31, 2024 | $13.6B |
| FY2025, ended Dec 31, 2025 | $14.0B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $13.6B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 8.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1000M |
| FY2017, ended Dec 31, 2017 | 984M |
| FY2018, ended Dec 31, 2018 | 938M |
| FY2019, ended Dec 31, 2019 | 934M |
| FY2020, ended Dec 31, 2020 | 920M |
| FY2021, ended Dec 31, 2021 | 924M |
| FY2022, ended Dec 31, 2022 | 906M |
| FY2023, ended Dec 31, 2023 | 909M |
| FY2024, ended Dec 31, 2024 | 910M |
| FY2025, ended Dec 31, 2025 | 908M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 914M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.13B | $252M |
| FY2017, ended Dec 31, 2017 | $2.56B | $242M |
| FY2018, ended Dec 31, 2018 | $5.10B | $232M |
| FY2019, ended Dec 31, 2019 | $2.96B | $217M |
| FY2020, ended Dec 31, 2020 | $2.55B | $224M |
| FY2021, ended Dec 31, 2021 | $527M | $230M |
| FY2022, ended Dec 31, 2022 | $3.62B | $289M |
| FY2023, ended Dec 31, 2023 | $293M | $362M |
| FY2024, ended Dec 31, 2024 | $929M | $387M |
| FY2025, ended Dec 31, 2025 | $1.48B | $419M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $636M | $412M |
Valuation
At current price- Market Cap
- $282B
- P/E
- 39.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 13.6×
- Price / Book
- 14.7×
- EV / EBITDA
- 27.4×
Growth
Trailing 12 months- Revenue (TTM)
- $20.8B
- Revenue Growth YoY
- 20.3%
- Revenue CAGR 3Y
- −4.1%
- Revenue CAGR 5Y
- 4.1%
- EPS Growth YoY
- 40.4%
- Net Income Growth YoY
- 41.0%
Profitability
Trailing 12 months- Gross Margin
- 60.2%
- Operating Margin
- 40.8%
- Net Margin
- 34.3%
- FCF Margin
- 35.2%
- Return on Equity
- 39.7%
Earnings
Trailing 12 months- Net Income
- $7.11B
- EPS (diluted)
- $7.71
- EBITDA
- $10.6B
- Operating Income
- $8.46B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $4.21B
- Total Debt
- $13.6B
- Net Debt
- $9.34B
- Total Assets
- $36.8B
- Total Liabilities
- $17.7B
- Shareholders' Equity
- $19.2B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $9.90B
- Capital Expenditure
- $2.58B
- Free Cash Flow
- $7.32B
Dividends and risk
Last 12 months- Dividend Yield
- 1.8%
- Dividend / Share
- $5.68
- Beta (5Y)
- 1.35
Every ratio is calculated from the company’s reported figures.